Mike Tyson , 58, is embroiled in a €1.46 million ($1.59 million) legal battle after allegedly breaching an agreement with a gambling promotional company by fighting 27-year-old Jake Paul in November . The lawsuit was filed by Medier, a media company promoting gambling brand Rabona, accusing Tyson of failing to honor a deal signed with the Cyprus-based business in January. The legal action was initiated at London's High Court in October, prior to the fight. Tyson and his fighting venture Tyrannic are said to have reneged on their agreement with Medier in March, citing a breach of their own. The fight against Paul , initially scheduled for July 20, was announced on the same day. Jake Paul trolls Tommy Fury after old rival pulled out of Darren Till fight Tyson Fury going into 'destroy mode' against Oleksandr Usyk as plan emerges Paul emerged victorious over Tyson by unanimous decision at the A&T Stadium in Dallas, Texas, on November 15 before a crowd exceeding 73,000 spectators. In the lawsuit, Medier argues that their actions did not warrant a breach, and Tyson's abrupt exit resulted in €1.46 million in damages. "The true reason for Mr Tyson and Tyrannic's hasty and unlawful termination was because Mr. Tyson had agreed [to] a deal, sponsored by Netflix, to fight the influencer Jake Paul," stated Medier and their legal team. Tyson and Tyrannic have yet to formally respond to the lawsuit but are expected to file a defense in the near future. Both parties were contacted for comment by Express Sports US . Despite the fight's lack of powerful punches and numerous streaming delays, it proved to be a significant commercial success for Netflix . The media behemoths announced that streaming "peaked at 65 million concurrent streams watching around the world, with 38 million concurrent streams in the United States," according to a Netflix press release. Paul reportedly pocketed a $40 million purse while Tyson took home $20 million. The earnings were slightly skewed because Paul promoted the fight and because of his large social-media following. The fight was also peppered with ads for sports betting company DraftKings. "This is one of those situations when you lost but still won," Tyson penned on X a day after the bout. "I'm grateful for last night. No regrets to get in [the] ring one last time." READ MORE: Reason behind Mike Tyson's odd glove biting in Jake Paul fight emerges Tyson Fury cuts off Oleksandr Usyk with fierce promise during face off Sydney Thomas shares message from Jake Paul she received at Tyson fight "I almost died in June. Had 8 blood transfusions. Lost half my blood and 25lbs in hospital and had to fight to get healthy to fight so I won," he added. "To have my children see me stand toe to toe and finish 8 rounds with a talented fighter half my age in front of a packed Dallas Cowboy stadium is an experience that no man has the right to ask for. Thank you."188 jili casino/super ace 。

Central Connecticut State defeats Binghamton 64-56Patriots release offensive starter, add O-lineman from DolphinsBonus shares 2024: Shares of Kothari Products surged over 7 per cent in intra-day trade on Monday, December 30 following the board's approval to bonus share issue in the ratio of 1:1. This was the second straight day of gains for Kothari Products stock, with the scrip rallying 12 per cent during this period. In an exchange filing on Friday, December 27, Kothari Products informed that its Board of Directors, at its board meeting held today, recommended the issue of bonus shares in the ratio of 1:1, subject to the approval of the members through postal ballot. This means that every shareholder who owns one stock of the company as of the record date will receive another stock at no additional cost. However, the company has not yet announced the record date for the bonus share issue . The company's board also approved increasing the authorized share capital from Rs. 31,50,00,000 to ₹ 61,50,00,000, subject to the approval of the members through postal ballot. Stock Price Trend Following this development, Kothari Products share price surged as much as 7.37 per cent to the day's high of ₹ 209.70. The stock opened at ₹ 199.15 as against its previous close of ₹ 195.30. The stock hit its 52-week high of ₹ 227.35 last week, on December 26, while its 52-week low stands at ₹ 111.15, which it touched on March 13, 2024. So far this month, the stock has rallied 30 per cent, while it has rallied 50 per cent in the last six months. On a one-year basis, Kothari Products share price is up 61 per cent. Kothari Products, engaged in sectors such as real estate, investments and international trading of exports and imports, is a small-cap company with a market capitalisation of ₹ 600 crore. Kothari Products Bonus Shares History This is the third bonus share action by Kothari Products. The small-cap firm had first approved bonus shares in the ratio of 2:1 in March 2014. Meanwhile, it announced a second bonus share issue in 2016 in a 1:2 ratio, suggests data from Trendlyne. Disclaimer: The views and recommendations above are those of individual analysts or broking companies, not Mint. We advise investors to check with certified experts before making any investment decisions.

New Delhi : External Affairs Minister (EAM) S. Jaishankar is set to embark on a three-day official visit to the State of Qatar from December 30, the Ministry of External Affairs said on Sunday. The MEA in an official statement said that during his visit, the EAM would meet with Qatari Prime Minister and Foreign Minister Sheikh Mohammed bin Abdulrahman bin Jassim Al Thani. The visit also aims to review various aspects of bilateral relations between India and Qatar with discussion on key areas, which include political, trade, investment, energy, security, cultural, and people-to-people relations. “EAM’s visit will enable both sides to review various aspects of bilateral relations, including political, trade, investment, energy, security, cultural, and people-to-people, as well as the regional and international issues of mutual interest,” the MEA said. EAM Jaishankar will depart from Qatar on January 1. India and Qatar share warm and friendly relations, marked by regular high-level interactions to further strengthen their partnership. Their most recent interaction occurred during EAM Jaishankar’s official tour to Qatar and Bahrain from December 6 to 9. During the visit, he met Qatar’s Minister of Commerce and Industry, Faisal bin Thani Al Thani, and Minister of State, Ahmed Al Sayed, on the sidelines of the Doha Forum. In late October, the two countries held the fifth round of Foreign Office Consultations. Both sides comprehensively reviewed the entire spectrum of India-Qatar bilateral relations, including high-level exchanges, trade, investment, energy, education, culture, and people-to-people ties. Discussions also explored avenues to deepen the relationship in areas such as renewable energy, fintech, start-ups, and technology. They exchanged perspectives on important regional and global issues of mutual interest, as noted by the MEA in a press statement. Earlier, on September 9, EAM Jaishankar met Qatar’s Prime Minister Mohammed bin Abdulrahman Al Thani in Saudi Arabia to discuss advancing bilateral ties. According to the MEA, cooperation between India and Qatar has been steadily growing within an excellent framework provided by their historically close ties and regular, substantive engagement at the highest levels of government. The large, diverse, and accomplished Indian community in Qatar significantly contributes to the country’s progress while nurturing the bonds of deep-rooted friendship and multifaceted cooperation between the two nations.

President-elect Donald Trump's cabinet picks have been mostly great so far, but Trump has a history of making bad choices. One of those bad choices, according to conservatives, is Trump's nominee for Surgeon General. No, it's not Ben Carson ... it's Dr. Janette Nesheiwat, whose resume during the COVID-19 lockdowns isn't stellar. Why? Here's Nesheiwat on Fox Business praising Facebook's approach to censoring anti-vaccine "disinformation" and hoping that other social media platforms would follow suit. Trump's pick for Surgeon General, Janette Nesheiwat, praised Facebook for censoring anti-vaccine information, adding that she will "hope and pray" other social media companies do the same. pic.twitter.com/Zqpz6ktLWs Nesheiwat was also a BIG fan of masking and social distancing. Janette Nesheiwat endorsed masks for children, promoted COVID vaccination for all age groups, and approved of censorship by social media companies. pic.twitter.com/8UHq7B4YLk Look, there's a lot we didn't know about COVID. But we know it now, so why regress? This is like when former Planned Parenthood President Dr. Leana Wen told CNN in December of 2021 that "cloth masks a little more than facial decoration" and don't work — after we'd all been forced to wear cloth masks. Or when President Joe Biden promised you wouldn't contract or spread COVID if you got the vaccine. Then Biden got COVID at least twice despite double-masking and getting every booster available. But no, we don't want anyone who praised social media for censoring discussion of the vaccine and its effectiveness. Trump's pick for Surgeon General, Janette Nesheiwat, praised Facebook for censoring anti-vaccine information & accounts like mine and RFK’s specifically, adding that she will "hope and pray" other social media companies do the same. Pick someone else🙏 pic.twitter.com/r2gEekxwm9 I don't want her anywhere near health policy This is totally unacceptable Disastrous pick. What is DJT doing? I will contact everyone I can to prevent her confirmation. Let's hope she has revised her stance on these things in light of all the new information that has come out since the time of this interview. She allegedly has ... but to praise Facebook's censorship efforts? That's hard to forgive. This really is a pretty bad pick. Don't know who was pushing this with Trump but they should be fired. Hard to find a worse pick for this position. So disappointing. Pull this nomination back immediately! Absolute garbage pick. I can't - no sane person said this or believed it - she can't be anywhere near health. She's as bad as Fauci. Here's co-founder of "far-right terrorist organization" Moms for Liberty, Tiffany Justice: Never again. Masks are not source control. They do not stop transmission. Masks harmed our children and we will NEVER allow this to happen again. Unacceptable choice for Surgeon General. So disappointing. https://t.co/fDjbQDRK01 To be clear, I have met Janette and she couldn’t have been nicer. She has been very loyal to President Trump which is wonderful and incredibly important. The problem is her position on the forced masking of children. So many children have been hurt. Parents won’t forget that. There were many other more qualified physicians who could have been appointed to this role. A lot of people in the replies favor Florida’s Surgeon General Joseph Ladapo, who was handpicked by Gov. Ron DeSantis, the country's best governor. So Nesheiwat was a clueless as everyone else during the pandemic, but word is that she's changed? But why her when there are so many other options? ***BARCELONA, Spain — Robert Lewandowski converted a first-half penalty kick to become the third player to score 100 goals or more in the Champions League, behind Cristiano Ronaldo and Lionel Messi. Lewandowski calmly sent a low shot into the net from the spot in the 10th minute to give Barcelona a 1-0 lead against Brest. Lewandowski trails the 129 goals of Messi and the 141 of Ronaldo, according to UEFA. Lewandowski needed 125 games to reach his milestone — two more games than Messi and 12 fewer than Ronaldo. It was Lewandowski’s sixth Champions League goal this season. It’s the ninth season in which the Poland striker has scored six or more goals. The 36-year-old Lewandowski is having a standout campaign, having scored 21 goals for Barcelona in 19 appearances. He is the Spanish league’s scoring leader with 15 goals from 14 matches. He scored 14 goals in the team’s last 10 matches in all competitions. Source: AP

US stocks mostly rose Friday after a report showed a healthy jobs market, and Paris rallied as President Emmanuel Macron vowed to serve out his full term and end France's political crisis. Oil fell on concerns of oversupply and Bitcoin held at a level over $100,000 after hitting records Thursday. The world's biggest economy gained 227,000 jobs in November, more than analysts expected and up from a revised 36,000 in October, said the US Department of Labor. "The US jobs market has emphatically rebounded following October's disappointing data," said Neal Keane, head of global sales trading at ADSS. October's figures had been depressed by hurricanes and workers' strikes, while November's increases may have been exaggerated by the end of a strike at Boeing in particular -- and by retail hiring ahead of the holiday season. US stocks mostly closed higher, with the broad-based S&P 500 and tech-focused Nasdaq both hitting fresh records, although the Dow retreated slightly. Investors are mostly betting that November's jobs numbers, while comforting, are probably not strong enough to deter the Federal Reserve from cutting interest rates again this month. "Investors needed a reassuring jobs report and that's exactly what they got," said eToro analyst Bret Kenwell. "The market still favors a rate cut from the Fed later this month and this report may not change that expectation." The Paris stock market closed up 1.3 percent on "hope that President Emmanuel Macron will serve out his term and that a (French) budget can be passed in the coming weeks," noted Derren Nathan, head of equity research at Hargreaves Lansdown. Macron on Friday was holding talks with French political leaders on the left and right as he seeks to quickly name a new prime minister after Michel Barnier's government was ousted in a historic no-confidence vote. Macron adopted a defiant tone in an address to the nation Thursday evening, just 24 hours after parliament voted out Barnier over his 2025 budget plan, which included unpopular austerity measures forced through without a vote using special powers. The luxury sector benefitted also from hopes of a pickup in Chinese demand. Gucci owner Kering topped the Paris CAC 40 as its shares gained more than six percent, while LVMH rose more than three percent. French video game company Ubisoft jumped 13 percent on takeover speculation. Frankfurt closed slightly higher, other continental markets were mixed, and London slid. In Asia, shares in Seoul sank more than one percent and the won weakened to about 1,420 per dollar as lawmakers prepared to hold an impeachment vote Saturday after President Yoon Suk Yeol's dramatic, short-lived imposition of martial law this week. While analysts said the economic fallout from the crisis would likely be limited, a political storm is ongoing. Hong Kong and Shanghai rallied as investors grew hopeful of fresh stimulus when top Chinese leaders including President Xi Jinping meet to discuss economic policy next week. Bitcoin hovered above $100,000 after having blasted to the historic peak of $103,800 Thursday on news that US President-elect Donald Trump had picked crypto proponent Paul Atkins to head the nation's markets regulator. New York - Dow: DOWN 0.3 percent at 44,642.52 points (close) New York - S&P 500: UP 0.3 percent at 6,090.27 (close) New York - Nasdaq Composite: UP 0.8 percent at 19,859.77 (close) Paris - CAC 40: UP 1.3 percent at 7,426.88 (close) Frankfurt - DAX: UP 0.1 percent at 20,384.61 (close) London - FTSE 100: DOWN 0.5 percent at 8,308.61 (close) Tokyo - Nikkei 225: DOWN 0.8 percent at 39,091.17 (close) Hong Kong - Hang Seng Index: UP 1.6 percent at 19,865.85 (close) Shanghai - Composite: UP 1.1 percent at 3,404.08 (close) Euro/dollar: DOWN at $1.0566 from $1.0591 on Thursday Pound/dollar: DOWN at $1.2740 from $1.2760 Dollar/yen: DOWN at 149.97 yen from 150.09 yen Euro/pound: DOWN at 82.93 from 82.97 pence West Texas Intermediate: DOWN 1.6 percent at $67.20 per barrel Brent North Sea Crude: DOWN 1.4 percent at $71.12 per barrel gv/rl/bys/ahaFans are calling out Donatella Versace for heavily editing her photos from Elton John’s charity gala premiere of The Devil Wears Prada: The Musical in London over the weekend. The Italian fashion designer, 69, shared a carousel of photos from the event via Instagram featuring stylish photos of her posing solo in a gold sparkly mini dress and with famous pals like Vanessa Williams, Anna Wintour and the Rocket Man singer himself. In one particular photo, Versace appeared to look “unrecognisable,” as some fans pointed out in the comments section, as she stood near a black SUV. “Donatella said new face, who this ?” one person wrote on X after seeing the edited snap. While several of her followers theorised that maybe she went under the knife to achieve the drastic new look, her face appeared normal in several other pictures shared from the event. That led fans to believe that Versace had just used a little Photoshop to give herself a “new face” in one of the photos. “That first pic had me! It doesn’t appear like Donatella Versace got new work done, it was just a good filter & some editing,” tweeted one user, with another joking, “Babe wake up new Donatella face just dropped.” “False alarm everyone Donatella Versace’s face is still the same someone just had free time and photoshop,” added another. “Someone set Donatella up with that edit OMG ... But anyway, however she looks, she’s still gorgeous because she’s a kind and loving woman,” said a third. Though the socialite has never explicitly confirmed having plastic surgery, her face has appeared to have drastically changed over the years. Many plastic surgeons believe she has had Botox, a facelift and lip fillers done over the years. In a 2010 interview, Versace said she didn’t believe in a “natural” look for women. “I don’t even know what my natural colour is. Natural? What is natural? What is that?” she said at the time. “I do not believe in totally natural for women. For me, natural has something to do with vegetables.” This story originally appeared on New York Post and was reproduced with permission— Court Rules in Favor of Heron in Patent Lawsuit Against Fresenius Kabi USA , LLC — SAN DIEGO , Dec. 3, 2024 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company, today announced that the U.S. District Court for the District of Delaware ruled in Heron's favor in the Company's patent litigation against Fresenius Kabi USA , LLC with respect to CINVANTI® (aprepitant) injectable emulsion. The district court found that Heron's U.S. Patent Nos. 9,561,229 and 9,974,794, which expire in 2035, are valid and would be infringed by Fresenius' proposed generic product. The district court decision concludes the litigation initiated in July 2022 in response to Fresenius' submission of an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval of a generic version of CINVANTI®. As a result of the decision, Heron will seek an order from the Court prohibiting Fresenius from launching its generic CINVANTI® until after the expiration of the patents in 2035. This decision is subject to appeal. "We are pleased with this anticipated result of the proceeding and will continue to vigorously defend the CINVANTI® patent estate in the future," said Craig Collard, Chief Executive Officer of Heron. "The team at Heron takes great pride in the result of our successful history of developing injectable products, which is demonstrated by the strength of our intellectual property and the performance of our innovative drugs like CINVANTI® in serving patients with serious unmet needs." About Heron Therapeutics, Inc. Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com . Forward-looking Statements This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. Therefore, you should not place undue reliance on forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements are set forth in our most recent Annual Report on Form 10-K and any subsequent Quarterly Reports on Form 10-Q, and in our other reports filed with the Securities and Exchange Commission, including under the caption "Risk Factors." Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law. Investor Relations and Media Contact: Ira Duarte Executive Vice President, Chief Financial Officer Heron Therapeutics, Inc. iduarte@herontx.com 858-251-4400 View original content to download multimedia: https://www.prnewswire.com/news-releases/us-district-court-upholds-validity-of-cinvanti-patents-302321651.html SOURCE Heron Therapeutics, Inc.

Ever-changing PWHL ready to launch Season 2IRVING, Texas , Nov. 26, 2024 /PRNewswire/ -- RumbleOn, Inc. (NASDAQ: RMBL) (the "Company" or "RumbleOn") announced today that it has commenced a $10.0 million fully backstopped registered equity rights offering (the "Rights Offering"), pursuant to which the Company is expected to receive aggregate gross proceeds of $10.0 million , less expenses related to the Rights Offering. The Company intends to use the proceeds from the Rights Offering for general corporate purposes which may include repayment of the Company's convertible senior 6.75% promissory notes due January 1, 2025 . The proceeds raised will also satisfy, in part, the additional capital financing obligations of the Company pursuant to a recent amendment to the Company's credit agreement with Oaktree. The Company is distributing at no charge to the holders of (i) its Class A common stock, par value $0.001 per share (the "Class A common stock"), and (ii) Class B common stock, par value $0.001 per share (the "Class B common stock" and, together with the Class A common stock, the "common stock"), in each case as of the close of business on November 25, 2024 (the "Record Date"), non-transferable subscription rights (the "Subscription Rights") to purchase up to 2,392,344 shares of Class B common stock at price of $4.18 per share (the "Subscription Price"). The aggregate subscription value of all shares of Class B common stock available for purchase in the Rights Offering is $10.0 million . Each holder of common stock as of the Record Date (each, an "Eligible Stockholder") will receive one Subscription Right for each share of the common stock owned as of the Record Date. Each Subscription Right entitles the holder to purchase 0.0677 shares of Class B common stock. The Company will not issue any fractional shares of Class B common stock in the Rights Offering. Instead, the Company will round down the aggregate number of shares of Class B common stock the Eligible Stockholders are entitled to receive to the nearest whole number. Accordingly, as each Subscription Right represents the right to purchase 0.0677 shares of Class B common stock, an Eligible Stockholder must hold at least 15 shares of Class A common stock or Class B common stock to receive sufficient Subscription Rights to purchase at least one share of Class B common stock in the Rights Offering. Eligible Stockholders will not be entitled to exercise an over-subscription privilege to purchase additional shares of Class B common stock that may remain unsubscribed as a result of any unexercised Subscription Rights. The Subscription Rights will expire and will have no value if they are not exercised prior to 5:00 p.m. Eastern Time , on the expiration time for the Rights Offering (the "Expiration Time"), which is currently expected to be 5:00 p.m. Eastern time on December 12, 2024 , unless the Company, in its sole discretion, extends the period for exercising the Subscription Rights. Subject to the terms and conditions of the Support and Standby Purchase Agreement (defined below), the Company reserves the right to cancel, terminate, amend, or extend the Rights Offering at any time prior to the Expiration Time. On November 26 , 2024, the Company entered into a support and standby purchase agreement (the "Support and Standby Purchase Agreement") with Stone House Capital Management, LLC, which is a holder of Class B common stock and is managed by Mark Cohen , a member of the board of directors of the Company (together with its affiliates, the "Standby Purchaser"), and Mark Tkach and William Coulter , each of whom is a holder of the Class B common stock and a member of the board of directors of the Company (collectively, the "Support Purchasers" and, together with the Standby Purchaser, the "Investors"). The Support and Standby Purchase Agreement provides, among other things, that (i) the Standby Purchaser will purchase from the Company in a private placement any shares of Class B common stock included in the Rights Offering that are not subscribed for and purchased by Eligible Stockholders (collectively, the "Backstop Securities") for the same per share Subscription Price payable by the Eligible Stockholders electing to exercise their Subscription Rights in the Rights Offering; and (ii) each Support Purchaser will exercise all of his respective Subscription Rights in full prior to the Expiration Time. Other Important Information The Subscription Rights will not be listed for trading on any stock exchange or market. Therefore, there will be no public market for the Subscription Rights. However, the shares of Class B common stock issued upon the exercise of the Subscription Rights will remain listed on The Nasdaq Capital Market of the Nasdaq Stock Market LLC under the symbol "RMBL." The Company expects that Broadridge Corporate Issuer Solutions, LLC, the subscription and information agent for the Rights Offering, will distribute subscription documents for the Rights Offering to Eligible Stockholders beginning on or about November 26, 2024 . Holders of shares of common stock held in "street name" through a brokerage account, bank or other nominee should contact their broker, bank or other nominee for details regarding participation in the Rights Offering. For any questions or further information about the Rights Offering, please contact the information agent, at (888) 789-8409 (Toll-Free), or via email at shareholder@broadridge.com . Neither the Company nor its board of directors has made or will make any recommendation to holders regarding participation in the Rights Offering. Holders should make an independent investment decision about whether to participate in the Rights Offering based on their own assessment of the Company's business and the Rights Offering. The offering of the Class B common stock pursuant to the Rights Offering is being made pursuant to the Company's existing effective shelf registration statement on Form S-3 (Reg. No. 333-281862) on file with the Securities and Exchange Commission (the "SEC") and a prospectus supplement (and the accompanying base prospectus) filed with the SEC on the date hereof. The information in this press release is not complete and is subject to change. This press release shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any offer, solicitation or sale of the securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful under the securities laws of such state or jurisdiction. The Rights Offering will be made only by means of the prospectus supplement (and the accompanying base prospectus) filed with the SEC on the date hereof. About RumbleOn RumbleOn, Inc. (NASDAQ: RMBL), operates through two operating segments: our Powersports dealership group and Wholesale Express, LLC, an asset-light transportation services provider focused on the automotive industry. Our Powersports group is the largest powersports retail group in the United States (as measured by reported revenue, major unit sales and dealership locations), offering over 500 powersports franchises representing 50 different brands of products. Our Powersports group sells a wide selection of new and pre-owned products, including parts, apparel, accessories, finance & insurance products and services, and aftermarket products. We are the largest purchaser of pre-owned powersports vehicles in the United States and utilize RideNow's Cash Offer to acquire vehicles directly from consumers. For more information on RumbleOn, please visit rumbleon.com . Cautionary Note on Forward-Looking Statements The Company's press release contains statements that constitute "forward-looking statements" within the meaning of The Private Securities Litigation Reform Act of 1995. Such forward-looking statements include, but are not limited to, those regarding the Company's plans to launch a Rights Offering, the anticipated final terms, timing and completion of the proposed Rights Offering, and the use of proceeds from the proposed Rights Offering. Forward-looking statements generally can be identified by words such as "anticipates," "believes," "continues," "could," "estimates," "expects," "intends," "hopes," "may," "plan," "possible," "potential," "predicts," "projects," "should," "targets," "would" and similar expressions, although not all forward-looking statements contain these identifying words. Such statements are subject to numerous important factors, risks and uncertainties that may cause actual events or results to differ materially from current expectations and beliefs, including, but not limited to, risks and uncertainties related to: whether the proposed transactions will be completed in a timely manner, or at all; the risk that all of the closing conditions for the proposed Rights Offering are not satisfied; the occurrence of any event, change or other circumstance that could cause the Company not to proceed with the Rights Offering; the determination of the final terms of the proposed Rights Offering; the satisfaction of customary closing conditions related to the proposed Rights Offering; risks related to the diversion of management's attention from RumbleOn's ongoing business operations; the impact of general economic, industry or political conditions in the United States or internationally, as well as the other risk factors set forth under the caption "Risk Factors" in the registration statement, as amended, and in RumbleOn's Annual Report for the year ended December 31, 2023 and Quarterly Reports on Form 10-Q for the quarters ended March 30, 2024 , June 30, 2024 and September 30, 2024 and in any other subsequent filings made with the SEC by RumbleOn. There can be no assurance that RumbleOn will be able to complete the proposed Rights Offering on the anticipated terms, or at all. Any forward-looking statements contained in this press release speak only as of the date hereof, and RumbleOn specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. View original content to download multimedia: https://www.prnewswire.com/news-releases/rumbleon-announces-commencement-of-10-0-million-fully-backstopped-registered-rights-offering-302316964.html SOURCE RumbleOn

Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726